294 related articles for article (PubMed ID: 22359298)
1. Epigenetics in ovarian cancer.
Seeber LM; van Diest PJ
Methods Mol Biol; 2012; 863():253-69. PubMed ID: 22359298
[TBL] [Abstract][Full Text] [Related]
2. Epigenetics of ovarian cancer: from the lab to the clinic.
Asadollahi R; Hyde CA; Zhong XY
Gynecol Oncol; 2010 Jul; 118(1):81-7. PubMed ID: 20421130
[TBL] [Abstract][Full Text] [Related]
3. Epigenome and DNA methylation in oral squamous cell carcinoma.
García MP; García-García A
Methods Mol Biol; 2012; 863():207-19. PubMed ID: 22359295
[TBL] [Abstract][Full Text] [Related]
4. The epigenetics of oral cancer.
Shaw R
Int J Oral Maxillofac Surg; 2006 Feb; 35(2):101-8. PubMed ID: 16154320
[TBL] [Abstract][Full Text] [Related]
5. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.
Abbosh PH; Montgomery JS; Starkey JA; Novotny M; Zuhowski EG; Egorin MJ; Moseman AP; Golas A; Brannon KM; Balch C; Huang TH; Nephew KP
Cancer Res; 2006 Jun; 66(11):5582-91. PubMed ID: 16740693
[TBL] [Abstract][Full Text] [Related]
6. Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers.
Wei SH; Chen CM; Strathdee G; Harnsomburana J; Shyu CR; Rahmatpanah F; Shi H; Ng SW; Yan PS; Nephew KP; Brown R; Huang TH
Clin Cancer Res; 2002 Jul; 8(7):2246-52. PubMed ID: 12114427
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of epigenetic alterations in human thoracic malignancies: epigenetic alterations in lung cancer.
Shinjo K; Kondo Y
Methods Mol Biol; 2012; 863():221-39. PubMed ID: 22359296
[TBL] [Abstract][Full Text] [Related]
8. The fundamental role of epigenetics in hematopoietic malignancies.
Galm O; Herman JG; Baylin SB
Blood Rev; 2006 Jan; 20(1):1-13. PubMed ID: 16426940
[TBL] [Abstract][Full Text] [Related]
9. Cancer epigenome.
Lechner M; Boshoff C; Beck S
Adv Genet; 2010; 70():247-76. PubMed ID: 20920751
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic analysis in the search for tumor suppressor genes.
Han ZG
Epigenomics; 2010 Aug; 2(4):489-93. PubMed ID: 22121966
[No Abstract] [Full Text] [Related]
11. The epigenetics of ovarian cancer drug resistance and resensitization.
Balch C; Huang TH; Brown R; Nephew KP
Am J Obstet Gynecol; 2004 Nov; 191(5):1552-72. PubMed ID: 15547525
[TBL] [Abstract][Full Text] [Related]
12. Epigenetics and ovarian cancer.
Nephew KP; Balch C; Zhang S; Huang TH
Cancer Treat Res; 2009; 149():131-46. PubMed ID: 19763434
[No Abstract] [Full Text] [Related]
13. Minireview: epigenetic changes in ovarian cancer.
Balch C; Fang F; Matei DE; Huang TH; Nephew KP
Endocrinology; 2009 Sep; 150(9):4003-11. PubMed ID: 19574400
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment.
Barton CA; Hacker NF; Clark SJ; O'Brien PM
Gynecol Oncol; 2008 Apr; 109(1):129-39. PubMed ID: 18234305
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic alterations as cancer diagnostic, prognostic, and predictive biomarkers.
Deng D; Liu Z; Du Y
Adv Genet; 2010; 71():125-76. PubMed ID: 20933128
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1.
Yang C; Cai J; Wang Q; Tang H; Cao J; Wu L; Wang Z
Gynecol Oncol; 2012 Feb; 124(2):325-34. PubMed ID: 22005523
[TBL] [Abstract][Full Text] [Related]
17. Epigenetics and miRNAs in human cancer.
Fabbri M; Calin GA
Adv Genet; 2010; 70():87-99. PubMed ID: 20920746
[TBL] [Abstract][Full Text] [Related]
18. Modulation of gene expression in ovarian cancer by active and repressive histone marks.
Bapat SA
Epigenomics; 2010 Feb; 2(1):39-51. PubMed ID: 22122747
[TBL] [Abstract][Full Text] [Related]
19. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R
Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
[TBL] [Abstract][Full Text] [Related]
20. Demethylation of the MCJ gene in stage III/IV epithelial ovarian cancer and response to chemotherapy.
Strathdee G; Vass JK; Oien KA; Siddiqui N; Curto-Garcia J; Brown R
Gynecol Oncol; 2005 Jun; 97(3):898-903. PubMed ID: 15894365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]